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The neurobiology of hallucinations is complex, and despite over a century of research it has yet
to be fully characterized. The observation that auditory hallucinations occur in healthy
individuals may provide new avenues for understanding its neurobiology in psychopathology.
Bayesian approaches to perception suggest that aberrant experiences can be conditioned, with
stronger effects in those prone to hallucinations. Through a combination of functional magnetic
resonance imaging and magnetic resonance spectroscopy, the present study investigated whether
differences in the endorsement of conditioned hallucinations was associated with differences in
anterior cingulate cortex (ACC) glutamate and GABA levels in a healthy, college-aged sample
that differed in their propensity to endorse perceptual abnormalities. Hallucinators were more
likely to endorse false percepts and were more confident in their responses during a Pavlovian
conditioning task that paired an auditory stimulus with a visual stimulus. Conditioned
hallucinations were positively correlated with self-report scores of hallucination-proneness in
daily life. Hallucinators had a higher ratio of glutamate to creatine in the ACC compared to a
control region, but there were no such differences in GABA/creatine ratios. Conservatively,
these results suggest that the predictive coding account of hallucinations in healthy individuals
overlaps with the underlying neurobiology of psychosis in disease states, and that such an
approach may be especially useful for understanding psychosis risk across development.

Keywords: Auditory Hallucinations, Predictive Coding, Magnetic Resonance Spectroscopy,
Perceptual Abnormalities, Functional Magnetic Resonance Imaging.
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Magnetic Resonance Spectroscopy Investigation of Conditioned Auditory Percepts
Despite over a century of research, the pathophysiology of psychosis has yet to be fully
characterized. The neurobiology of psychosis is complex and likely involves genetic, molecular
and structural abnormalities across diverse brain regions (Lakhan & Vieira, 2009). Clinically,
psychosis is characterized by a heterogeneity of symptoms including hallucinations, the strong
conviction of a sensory experience in the absence of a percept, and delusions, holding strong
beliefs in the absence of supporting evidence (American Psychiatric Association, 2013).
Psychotic experiences can contribute to the pathology of serious mental illnesses, such as
schizophrenia (SZ), which affects 1% of the world’s population (World Health Organization,
2012). The global public health impact of this severe and chronic mental illness is significant;
schizophrenia is among the top 10 causes of disability in developed countries (Chong et al.,
2016). Given the heterogeneity of clinical presentation and numerous risk factors, SZ likely
reflects a state of equifinality in which many different potential pathways can lead to similar
pathology (Uhlhaas et al., 2017). In order to elucidate more specific mechanisms, it is important
to isolate clinical characteristics that confer increased risk and identify their underlying
neurobiological mechanisms, thereby linking physiological markers of disease risk with
symptom phenomenology.
One promising approach for an improved understanding of psychosis in disease is through
characterizing the spectrum of psychotic-like experiences in healthy individuals (Zammit et al.,
2013). Although psychosis occurs within various psychiatric disorders, psychotic-like
experiences also occur in healthy individuals across development (Schlosser et al., 2012;
Unterrassner, Wyss, Wotruba, Haker, & Rössler, 2017). When psychosis is present in mental
illness, it contributes to marked changes in behavior, high levels of distress, and significantly
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impact daily functioning (Paolo Fusar-Poli, Borgwardt, et al., 2013). However, perceptual
aberrations alone are not necessarily associated with ill mental health (Goulding & Odehn,
2009). As many as 3% of individuals report psychotic-like experiences regularly, and 7% of
individuals report a lifetime prevalence of psychosis experiences (Linscott & van Os, 2013). As
many as 13.2% of the general population endorses hearing voices (Beavan, Read & Cartwright,
2011). These experiences include perceptual abnormalities (PA), which involve perceiving
stimuli without an actual percept, as well as hallucinations, in which the experience of PA is
accompanied by a strong belief in the reality-basis of these percepts without supporting evidence
(Tucker et al., 1969). Understanding the phenomenology of psychosis on a continuum has
important implications for uncovering factors that contribute to increased risk of conversion to a
psychotic disorder, and characterizing potential overlap in underlying neurobiology of low level
perceptual abnormalities and hallucinations (Powers et al., 2019; Unterrassner, Wyss, Wotruba,
Ajdacic-Gross, et al., 2017). Furthermore, this approach may suggest new avenues for
prevention, early intervention, and treatment (Addington, Addington, Abidi, Raedler, &
Remington, 2017).
Perceptual abnormalities can include experiences such as hearing one’s name being called,
seeing shadows in the shape of a person, experiencing the sensation of a cell phone vibrating in
one’s pocket or hearing song lyrics (Marshall et al., 2019). Adolescence through young
adulthood marks the prototypical period of symptom onset (Tor et al., 2018). For these
individuals at clinical high risk, approximately 25% - 35% will eventually convert to a psychotic
illness (Addington et al., 2015; Cannon et al., 2008), with approximately one-third converting in
the first year after onset, another third in the second year, and the final third more than two years
after onset (Powers et al., 2019). Yet for some, these experiences continue into adulthood

2

without accompanying distress or functional impairment (Pinheiro, Schwartze, & Kotz, 2018; A
R Powers & Corlett, 2018). For another subset of individuals, attenuated psychotic symptoms
remit completely (Addington et al., 2019; Simon et al., 2013). Characterizing clinical and
neurobiological characteristics that distinguish these groups at onset could greatly improve
targeted early intervention efforts.
Auditory perceptual abnormalities may be especially important from a phenomenological
perspective for understanding conversion risk given that auditory verbal hallucinations occur in
60-80% of all patients with schizophrenia (Shergill et al., 1998). Understanding the continuum of
shared neurobiology of perceptual abnormalities and auditory hallucinations will help provide
new understanding of risk factors for conversion, and may lead to improvements in early
detection and prevention. Yet linking the spectrum of psychotic-like symptoms to neurobiology
may require a computational and cognitive neuroscience perspective (Adams, Stephan, Brown,
Frith, & Friston, 2013; Corlett, Frith, & Fletcher, 2009; Sterzer et al., 2018). Bayesian
approaches to perceptual learning suggest that these experiences are not simply passive
processes, but rather may be informed by previous conditioning (Corlett et al., 2009). Higher
order beliefs in the reality basis of these experiences is one of the distinguishing characteristics
between perceptual illusions versus hallucinations (Teufel et al., 2015). Under a predictive
coding approach, hallucinations occur when top-down priors beliefs about perceptual
experiences are maintained without conforming sensory input, resulting in the creation of a
sensory input that conforms with prior beliefs (Powers, Mathys, & Corlett, 2017; Sterzer et al.,
2018). New computational approaches (Mathys, 2017; Mathys et al., 2014) allow for behavioral
and physiological data to be leveraged for modelling higher-order beliefs to confirm whether
perceptual experiences are informed by differences in the weighting of prior expectations versus
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sensory input. It also provides a powerful tool for linking the neurobiology of perception and
cognition with systems-level approach to the phenomenology of psychosis across a continuum.
Neurobiology of Hallucinations and Perceptual Abnormalities
Initial evidence suggests that conversion risk may be reflected in both the overlapping
neural basis of hallucinations and in the neurocognitive impairments that characterize psychosis.
The neurobiology of hallucinations has increasingly shifted toward emphasizing the role of
altered N-methyl-D-aspartate (NMDA) receptor functioning (Horga & Abi-Dargham, 2019; A R
Powers, Gancsos, Finn, Morgan, & Corlett, 2015). Converging evidence from basic and clinical
research indicate that NMDA receptor antagonists, such as Ketamine, can model both the
phenomenology and neurobiology of hallucinations (Marsman et al., 2013; Powers et al., 2015).
NMDA receptor antagonists induce auditory perceptual abnormalities in healthy individuals
(Krystal et al., 1994) and increase the frequency and intensity of auditory hallucinations in
patients with psychosis (Kantrowitz & Javitt, 2012). These effects are most likely achieved
through the role of NMDA receptor antagonists in increasing the release of the neurotransmitter
glutamate through the inhibition of GABAergic interneurons (de Jonge, Vinkers, Hulshoff Pol,
& Marsman, 2017; Kittelberger, Hur, Sazegar, Keshavan, & Kocsis, 2012; Paoletti, Bellone, &
Zhou, 2013) Specifically, NMDAR hypofunction increases activation of top-down frontal
activity, including the anterior cingulate cortex (ACC), which results in the suppression of
sensory signaling through primary sensory areas (Ranson et al., 2019). In animal models, both
the acute and chronic administration of NMDA receptor antagonist reliably reproduce the
neurobiological abnormalities observed in the pathology of psychosis (Cordon et al., 2015;
Kittelberger et al., 2012; Kort et al., 2017; Michaels, Long, Stevenson, Chrobak, & Chen, 2018).
This includes reduction in the number of GABAergic interneurons in hippocampal regions
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(Cunningham et al., 2006), increases in anterior cingulate cortex glutamate levels (Stone et al.,
2014) and decreased synaptic plasticity in the prefrontal cortex (Zhang, Behrens, & Lisman,
2008). Several studies (Kokkinou, Ashok, & Howes, 2018; Stone et al., 2010; White et al., 2018)
have demonstrated that cortical NMDAR hypofunction results in other neurobiological
abnormalities consistently reported in psychosis, including increased striatal dopamine release
(Kokkinou et al., 2018; Stone et al., 2010). However, given the complex interaction of these two
neurotransmitter symptoms, (McCutcheon, Krystal, & Howes, 2020) and mixed findings
regarding their role across different clinical aspects of psychotic illness, more evidence is needed
to further characterize the effects of NMDA hypofunction on subcortical dopamine in the
etiology of hallucinations.
In vivo studies of glutamate and GABA levels in individuals with psychosis provide
further evidence of the putative role of NMDA hypofunction in the neurobiology of
hallucinations (Kegeles et al., 2012; Rowland et al., 2013). 1H magnetic resonance spectroscopy
(1H-MRS or MRS) is a neuroimaging technique that assesses the chemical composition of
tissues in a noninvasive manner by using the magnetic resonance of hydrogen to determine the
concentration of metabolites (Chiappelli, 2018; Cohen & Sweet, 2011; Faro, Mohamed, Law, &
Ulmer, 2012). MRS allows for the in vivo measurement of various metabolites, including
glutamate (Glu), GABA, glutamine, or the combination of glutamate and glutamine
(Glx)(Dhamala et al., 2019). A meta-analysis of 1H- MRS studies (Marsman et al., 2013) in
patients with psychosis compared to healthy controls reported increased levels of glutamate in
the medial prefrontal cortex. Individuals with first-episode psychosis appear to have increased
level of glutamate in the anterior cingulate cortex compared to healthy controls, and glutamate
levels in frontal regions are positively correlated with psychosis symptom severity (Kegeles et
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al., 2012). Unmedicated patients with first-episode psychosis also demonstrate increased Glu
levels in the ACC (Poels et al., 2014).
Findings from MRS studies investigating glutamate levels in those at clinical high risk
(CHR) for psychosis are somewhat mixed. Several studies report no differences in the level of
glutamate (Fusar-Poli et al., 2011; Stone et al., 2009) or Glx (Keshavan et al., 2009; Purdon,
Valiakalayil, Hanstock, Seres, & Tibbo, 2008; Yoo et al., 2009) between CHR and health
controls. One study reported increased levels of Gln (Stone et al., 2009) and another increased
Glu/Gln ratio (Tibbo et al., 2004) in high-risk unmedicated individuals compared to controls. A
large multi-year study of CHR individuals (Addington et al., 2007, 2012) that includes a MRS
neuroimaging component is currently being completed at several sites across North America and
will likely contribute significantly increased sample in order to provide additional power to
detect between-group differences in glutamate levels.
Fewer studies have examined alterations in GABA in high-risk, first-episode, or chronic
patients with psychosis. Increased GABA levels have been reported in chronic patients with
psychosis (Choe et al., 1994) and after four-to-six months of antipsychotic medication treatment
(Choe et al., 1996). MRS studies of individuals high in schizotypal traits demonstrated increased
levels of glutamate and decreased GABA levels relative to health controls (Fervaha &
Remington, 2013; Lin et al., 2012) but such differences may be task-dependent (Duncan, Enzi,
Wiebking, & Northoff, 2011). Two studies (Rowland et al., 2013 and Rowland et al., 2015)
report decreased GABA concentrations in chronic patients, another (Ongur et al.) reported
increased GABA in the anterior cingulate of chronic patients.
Two recent meta-analyses (Egerton, Modinos, Ferrera, & McGuire, 2017; Kumar, Vajawat,
& Rao, 2020) examined GABA levels in chronic patients with psychosis and in CHR
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individuals. In patients with schizophrenia, GABA levels were lower in the anterior cingulate
cortex compared to healthy controls, but there were no between-group differences in other
frontal regions (Kumar et al., 2020). Yet when comparing CHR individuals to healthy controls,
there were no between-group differences across all MRS studies (Egerton et al., 2017) nor in
studies using other neuroimaging techniques including positron emission tomography (PET) and
single photon emission computed tomography (SPECT). Two separate studies (Wang et al.,
2016; Modinos et al., 2018) report no difference in GABA levels in those at ultra-high risk for
psychosis (those with clinical risk factors and a family history of psychosis), while one study (Da
Silva et al., 2019) reported higher GABA levels in those at clinical risk and another (de la
Fuente-Sandoval et al., 2016) in those at ultra-high risk. These mixed results suggest the need for
additional studies investigating the role of prefrontal GABA levels in the prodromal stages of
psychosis.
There are several potential explanations for the above-noted discrepancies across MRS
studies. There is some evidence that antipsychotic medications decrease glutamate levels
(Schwerk, Alves, Pouwels, & van Amelsvoort, 2014), including in the ACC. Between-study
differences in magnetic field strength may also contribute to mixed findings. There are many
methodological differences across studies that could impact the ability to detect differences,
including voxel size, voxel placement, and pulse sequence parameters. Few studies controlled for
differences in white matter and CSF volume and none of the studies compared findings to a
control region. Comparison across MRS studies examining differences in GABA levels is
especially difficult given the need for using J-editing techniques that distinguish GABA from
overlapping signals of other metabolites (Mikkelsen et al., 2017). When GABA MRS procedures
are implemented in a standardized fashion, the reliability and consistency of measurement is
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greatly increased (Mikkelsen et al., 2018). Although GABA concentrations are typically
referenced to total creatine (TCr) levels, due to its relative stability, there is some evidence that
phosphocreatine (PCr), which is a large component of the TCr signal, may be altered in disease
states (Turner & Gant, 2014). Given these challenges associated with measuring glutamate levels
in medicated individuals, the variability in GABA measurement across studies, and the unclear
role of glutamate and GABA in clinical high-risk individuals, additional studies are needed to
further elucidate these proposed neurobiological abnormalities across the spectrum of psychotic
experiences.
Dimensional Approaches to Perceptual Abnormalities
The endorsement and nature of psychotic-like experiences can be assessed through a
variety of approaches, including through self-report and structured clinical interview. In helpseeking populations, the Structured Interview for Prodromal States (SIPS) (Miller et al., 2003) is
the gold standard for clinical research and can be especially helpful for monitoring conversion to
psychosis (Cannon et al., 2008; Powers et al., 2019). It collects detailed information regarding
psychotic experiences including an individual’s level of conviction, distress, and changes in
behavior in response to PA. Yet the SIPS is time-consuming to administer, is primarily focus on
current symptoms, has not been normalized in healthy individuals, and was primarily designed
for use in non-clinical samples (Miller et al., 2002). The Structured Clinical Interview for DSM5 Disorders (SCID-5) (First, 2014), while also time-consuming to administer and requiring
supervised training in administration, has been utilized for both clinical and research purposes
and maps onto diagnostic criteria in order to rule out a current or past psychotic diagnosis
(Shankman et al., 2018).
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An individual’s predisposition toward experiencing perceptual abnormalities can be
reliably measured through self-report (Chan et al., 2019; Kim et al., 2010; Kline et al., 2016,
2012; Ratcliff, Farhall, & Shawyer, 2011). These measures have historically been developed
using a dimensional approach to understanding psychotic symptoms on a continuum (E. R.
Peters, Joseph, & Garety, 1995), in contrast to structured clinical interviews that are based on
discrete risk states (e.g., the SIPS) or categorical diagnostic labels (e.g., the SCID-5). Several
measures of perceptual abnormalities and psychotic-like experiences have been developed and
tested for use in healthy individuals (Ratcliff et al., 2011). Yet there is considerable variability in
the underlying constructs being measured across measures (Unterrassner, Wyss, Wotruba,
Ajdacic-Gross, et al., 2017). The Launay-Slade Hallucination Scale Revised (LSHS-R) (Bentall
& Slade, 1985; Launay & Slade, 1981) is a 12-item self-report measure of an individual’s
propensity to endorse hallucinations. It was designed for use in healthy individuals (Launay &
Slade, 1981), has strong psychometric properties including test-retest reliability (Waters,
Badcock, & Maybery, 2003), and has been normed in large undergraduate (Aleman,
Nieuwenstein, Böcker, & De Haan, 2001) and adolescent (Løberg, Gjestad, Posserud, Kompus,
& Lundervold, 2019) samples. Previous studies using the LSHS-R provide strong support for
hallucinations existing on a continuum given the scale’s reliability in measuring this construct
consistently across healthy individuals (Kråkvik et al., 2015), patients with psychosis, and those
with a history of hallucinations (Levitan, Ward, Catts, & Hemsley, 1996). The LSHS-R is a
particularly useful tool for examining current perceptual abnormalities in healthy individuals
given its utility in being able to reliably track these symptoms in those who covert to psychosis
and in instances where the persistence of these experiences is not associated with mental illness.
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Among adolescents and young adults who experience hallucinations, a portion will not
covert to a psychotic disorder but may go on to develop a broader constellation of traits
consistent with or similar to schizotypal personality disorder (STPD) (Rossi & Daneluzzo, 2002).
STPD is a mental health condition characterized by unconventional beliefs, social difficulties,
perceptual abnormalities, and paranoia (American Psychiatric Association, 2013). Although the
prevalence of schizotypal traits is high in CHR individuals, this overlap alone does not influence
the risk for conversion to psychosis (Zoghbi et al., 2019). While the diagnosis of STPD is
associated with functional decline and subjective distress, its prevalence in clinical samples is
low (APA, 2013), perhaps due to a lack of help-seeking behavior in this population (Barkus et
al., 2010). Indeed, many individuals high in schizotypal traits maintain adequate functioning, and
there may be a propensity toward this phenotype in certain professions such as psychics
(Pinheiro et al., 2018; Powers, Kelley, & Corlett, 2017), mediums, and shamans (Powers &
Corlett, 2018).
The Schizotypal Personality Questionnaire (SPQ) is a 75-item self-report questionnaire of
schizotypal traits in the general population (Raine, 1991). The SPQ has strong psychometric
properties (Callaway, Cohen, Matthews, & Dinzeo, 2014; Fonseca-Pedrero, Cohen, OrtuñoSierra, de Álbeniz, & Muñiz, 2017), has been tested and normed extensively in undergraduate,
young adult, and nonclinical samples (Rossi & Daneluzzo, 2002; Unterrassner, Wyss, Wotruba,
Ajdacic-Gross, et al., 2017; Unterrassner, Wyss, Wotruba, Haker, et al., 2017), and is consistent
with clinician ratings of schizotypal traits in healthy individuals without personality disorders
(Chan et al., 2019). Unlike other self-report measures that are limited to PA, subscales of the
SPQ also measure cognitive symptoms consistent with the prodrome of psychosis(Axelrod,
Grilo, Sanislow, & McGlashan, 2001; Callaway et al., 2014; Compton, Goulding, Bakeman, &
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McClure-Tone, 2009; Fonseca-Pedrero et al., 2017; Yaralian et al., 2000). The combined
cognitive-perceptual factor of the SPQ can therefore provide a strong indication of traits related
to the cognitive and perceptual abnormalities that are common across CHR, SZ, and STPD
individuals.
While there are currently significant clinical and research efforts aimed at identifying
factors that predict conversion to psychosis from prodromal states, few self-report measures of
perceptual abnormalities have been examined with respect to their predictive validity. The
Chapman Perceptual Aberration Scale (Chapman, Chapman, & Raulin, 1978), is a 35-item selfreport questionnaire that assesses psychotic-like experiences such as unusual perceptual
abnormalities, bodily sensations, and dissociation. It has strong predictive abilities across time
and cultures (Chan et al., 2015; Chapman, Chapman, Kwapil, Eckblad, & Zinser, 1994), and
maps onto other measures of schizotypal traits. As many as 10% or more of CHR individuals
who convert to a psychotic disorder are diagnosed with an affective form of psychosis such as
bipolar disorder with psychotic features or major depressive disorder with psychotic features
(Paolo Fusar-Poli, Bechdolf, et al., 2013). Previous studies (Chapman et al., 2020) demonstrate
that the Chapman scales may be especially useful for capturing the co-occurrence of mood and
perceptual symptoms.
Cognitive models of auditory hallucinations propose that the persistence of these
experiences is mediated by one’s beliefs (Garety & Hemsley, 1987). Delusions are tenaciouslyheld false beliefs that can include strongly held convictions related to the experience of
perceptual abnormalities. In line with the fully dimensional view of psychotic symptoms, and the
role of beliefs and expectation in the formation of these experiences, the Peters et al. Delusions
Inventory (PDI) is a 21-item self-report measure that assess an individual’s distress,
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preoccupation, and conviction associated with various delusional beliefs (Peters & Garety, 1996;
Peters et al., 1995). The measure has strong psychometrics properties and has been used in large
samples of healthy individuals (Peters, Joseph, & Garety, 1999), patients with psychosis (Peters,
Day, McKenna, & Orbach, 1999), and undergraduate population (Fonseca-Pedrero, Paino,
Santarén-Rosell, Lemos-Giráldez, & Muñiz, 2012).
Cognitive Impairment in the Prodrome of Psychosis
Cognitive deficits are a well characterized clinical feature of psychotic illness (Goldberg,
David, & Gold, 2003; Green, 1996; Green, Kern, Braff, & Mintz, 2000). Recent efforts to
identify and treat CHR individuals have focused on the neurocognitive profile of these
individuals including variability in cognitive abilities and related functioning at the onset of
symptoms, during the prodrome, and upon conversion to psychosis (Addington, Liu, et al.,
2017). Changes in cognition may not only be related to risk for conversion, but may precede
frank psychotic symptoms (Fusar-Poli et al., 2012)and therefore may be especially important for
early detection and prevention efforts.
CHR individuals who convert to psychosis on average have a lower full-scale IQ and
lower processing speed compared to those who not convert (Seidman et al., 2012). For a subset
of individuals, the onset of reduced processing speed occurs prior to the onset of attenuated
psychotic symptoms. Other studies (Addington, Liu, et al., 2017; Seidman et al., 2010) have
demonstrated working memory deficits and difficulties with verbal memory as markedly
impaired in CHR individuals and a strong predictor of eventual conversion. The Digit-Symbol
Coding subtest (Coding) of the Weschler Abbreviated Scale of Intelligence (WAIS-IV)
(Weschler, 2010) is a well-validated and commonly-used measure of processing speed that has
been tested in patient populations, large adult populations, and undergraduate samples (Cornelis
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et al., 2014). Poor performance on this neuropsychological measure is associated with worse
functioning in psychotic illness, and predicts the later severity of symptoms (Fusar-Poli et al.,
2012). The Letter-Number Sequencing task (LNS) is a measure of working memory abilities that
has been validated across several large samples, is known to be impaired in psychosis (Gold,
Carpenter, Randolph, Goldberg, & Weinberger, 1995), and is correlated with positive symptom
severity (Haut, Kuwabara, Leach, & Arias, 2000; Hurford, Marder, Keefe, Reise, & Bilder,
2011; Murtagh et al., 2010). The strong reliability and validity of both measures, their use in
clinical and non-clinical samples, their ease of administration, and their relation to psychosis
symptom emergence and severity, indicate strong ability to detect neurocognitive differences that
relate to underlying neurobiological vulnerability to psychosis.
Predictive Coding Account of Psychosis
Perceptual experiences are not merely passive “bottom-up” processes but rather are
informed by higher-order learning (Rao & Ballard, 1999; Seymour, 2004). This is supported by
evidence that individuals infer the cause of sensory information (von Helmholtz, 1867). For
example, the sensation of being tickled can be cancelled when anticipated, either from someone
else or oneself. In order to successfully navigate the world, perceptual experiences are learned
and inform expectations about future sensory experiences. These models of the world are
updated when novel perceptual information conflicts with previously learned expectations
(Adams et al., 2013; Sterzer et al., 2018). The accuracy of these predictions must be robust
enough to resist change yet flexible enough to adaptively incorporate new sensory information.
This predictive coding account of perception relies on the mathematical approach of Bayesian
inference (Corlett et al., 2009). A sensory prediction is represented as a probability (prior) and is
combined with incoming sensory data (likelihood, also represented as a probability) to create a
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posterior probability, which reflects the most likely outcome based on prior predictions and
current sensory experience (Sterzer et al., 2018).
As a theory of brain function, predictive coding provides an account of hierarchical sensory
learning in which low level sensory predictions contribute to higher-order beliefs or schemas
about the perceptual world (Corlett et al., 2009; Horga, Schatz, Abi-Dargham, & Peterson,
2014). Prediction errors occur when incoming data violates prior predictions (i.e., the difference
between the mean of the prior and the mean of likelihood probabilities). The reliability of priors
vs. sensory data is based on their respective weighting (Mathys et al. 2011). The overweighting
of priors or incoming sensory data can result in erroneous updating of internal working models
of the world or the creation of percepts that conform with expectations. If previously learned
associations and experiences are maintained in the absence of incoming sensory data (increase
precision of a prior belief), a percept is created that conforms with previous expectations (i.e.,
hallucination). If sensory data are too easily incorporated into internal working models
(increased precision of sensory data), individuals develop strongly held beliefs that resist change
(i.e., delusions)(Anandakumar, Connaughton, Coltheart, & Langdon, 2017; Corlett et al., 2009;
Corlett, Taylor, Wang, Fletcher, & Krystal, 2010)

.

Preliminary evidence provides support for hallucinations relying on disruption in the
weighting of prior beliefs. Yet it is unclear whether such weightings are disrupted at different
hierarchical levels. enhanced top-down signaling and increased precision of priors. Individuals
who hear voices demonstrate reduced bottom-up connectivity from Wernicke’s to Broca’s area
(Friston, 2005) and hallucinators are more susceptible to sensory conditioning, which has been
associated with an overweighting of prior beliefs (Powers, Mathys & Corlett, 2017). When
auditory information is uncertain, hallucinators are biased toward responding in a manner that is
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consistent with a stronger weighting of prior beliefs (Cassidy et al., 2018). This bias could also
be induced through the administration of amphetamines, consistent with the well-established role
of striatal dopamine in the etiology of psychosis. Yet other evidence suggests that auditory
verbal hallucinations (AVH) rely on weak priors given evidence that individuals who experience
AVH are inaccurate in predicting the sensory consequences of internal speech (Horga & AbiDargham, 2019; Kort et al., 2017).
Predictive coding provides a computational framework for linking the phenomenology of
hallucinations with the neurobiology of psychosis. GABA and glutamatergic functioning appear
critical to the E/I balance. but perhaps differentially across the hierarchy of the brain. Weak
priors at lower levels (primary sensory regions) may lead to relying on high-level abstract or
semantic prior beliefs. A decrease in the precision of priors may be related to glutamatergic
hypofunction and its effects on striatal dopamine release (Teufel et al., 2015). Ketamine and
other NMDA antagonists alters excitatory/inhibitory balance (Jardi & Deneve, 2013). This is
supported by evidence that perceptual abnormalities can be conditioned; when trained to
associated a light with a tone, individuals who experience hallucinations were more likely to
endorse perceiving the tone when the light was presented alone than those who do not experience
hallucinations (Powers, Mathys & Corlett, 2017).
Predictive coding is consistent with several adjacent theories of hallucinations. Although
individuals with psychotic disorders were especially susceptible to this effect (Kot & Serper,
2002), individuals without a diagnosed psychotic illness but who experience PA also endorsed
conditioned hallucinations during the task, suggesting a common mechanism between
pathological and phenomenological hallucinations. Individuals who experience perceptual

15

aberrations attribute importance to events that others would not find salient, a process that can be
viewed as a form of prediction error (Kapur, 2003).
Functional neuroimaging data of conditioned auditory percepts indicate that when making
correct rejections, hallucinators were less likely to engage the anterior cingulate cortex (ACC)
compared to non-hallucinators (Powers, Mathys & Corlett, 2017). The ACC has been
consistently implicated in both the neural activity of auditory verbal hallucinations (Zmigrod,
Garrison, Carr, & Simons, 2016) as well as stimulus detection prediction (den Ouden et al.,
2009) and audiovisual associative learning (Laurienti et al., 2003). It is involved in cognitive
control (Barch, 2017) and in source monitoring of censoring information (Yeung &
Nieuwenhuis, 2009). Yet the neurobiological underpinning of these ACC activation differences
is largely unknown.
Current Investigation
The present study investigated the neurobiology of conditioned hallucinations through the
use of MRS to collect in-vivo measurements of glutamate and GABA neurotransmitter levels in
healthy individuals that vary in their endorsement of perceptual abnormalities. When compared
to individuals who do not experience PA (STP- or minus), individuals who endorse PA
consistent with schizotypal personality traits (STP+ or plus), will 1) be more likely to endorse
false percepts (conditioned hallucinations), 2) will be more confident in their belief about the
conditioned hallucinations, 3) will demonstrate differences in fMRI activation patterns consistent
with the neurobiology of hallucinations, and 4) will demonstrate increased glutamate
concentrations (as measured by the ratio of total glutamate to total creatine) and decreased
GABA concentrations (as measured by the ratio of total GABA to total creatine) in the ACC
compared to glutamate and GABA concentrations in a control region (paracentral lobule).
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Through applying a predictive coding account of conditioned hallucinations in a healthy
undergraduate sample, the present investigation aimed to provide further support for the topdown role of perception in psychotic experiences along a continuum, as well determine whether
the neurobiological and cognitive mechanisms underlying perceptual aberrations overlap with
the putative role of NMDA receptor hypofunction in psychosis.
Methods
All study materials, participant recruitment and protocol procedures were approved by
the Institutional Review Board (IRB) of the Human Research Protection Program (HRPP) at the
University of Connecticut. All participants had the opportunity to read and discuss the consent
form and all participants provided informed consent before participating. Two groups of
participants were recruited: 1) individuals without a diagnosable psychiatric disorder who
endorse schizotypal traits (STP Plus/STP+) and 2) healthy individuals without a diagnosable
psychiatric disorder who do not endorse schizotypal personality traits (STP Minus/STP-). Study
recruitment occurred in two parts; during the first part (Phase A), participants were invited to
participate in an online survey through the Department of Psychological Sciences participant
pool. Those survey participants who met study criteria from Phase A were invited to the second
part of the study (Phase B) which included an in-person screening visit. If eligible following the
in-person screening visit, participants were enrolled in the neuroimaging portion of the study. In
addition to recruitment through the Participant Pool, Phase B participants were also recruited
though online and local advertisements in Storrs, Connecticut and Hartford, Connecticut. For
Phase B, exclusion criteria were as follows for all participants: 1) current diagnosis of an Axis I
psychiatric disorder (including psychotic disorders); 2) MRI contraindications and
claustrophobia; 3) subject-reported substance dependence or active use; 4) pregnancy or
possibility of pregnancy by self-report; 5) any medical or developmental problem that is known
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to impair cognition significantly such as intellectual disability, attention deficit hyper activity
disorder, Huntington’s disease, Down Syndrome, or traumatic brain injury; 6) individuals with
significant hearing impairment including those requiring the use of a sign-language translator;
and 7) individuals with significant vision impairment such that they are unable to able to read the
third line of a standard eye chart (with corrected vision).
Participants (Phase A)
The overall sample was comprised of 552 individuals, 98% of whom (542) were
undergraduate students enrolled in introductory psychology courses at the University of
Connecticut. Exclusion criteria for Phase A participants were as follows: 1) Self-reported firstdegree relative with history of a diagnosed psychotic disorder (e.g., schizophrenia,
schizoaffective disorder, major depressive disorder with psychotic features, or bipolar disorder
with psychotic features), 2) MRI contraindications and claustrophobia; 3) non-native English
speakers and 4) incomplete survey response data. Based on the above-mentioned criteria, 173
participants (31%) provided incomplete data and were excluded from further enrollment. Of the
remaining sample (n=379), a total of 137 survey participants (36%) were excluded based on the
following: first degree relative with psychiatric diagnosis (n=105, 27%), non-native English
speaker (n=21, 5%), MRI incompatibility (n=11, 2%). The remainder of the sample (n=242,
43%) were deemed eligible to continue and were invited via email to participate in Phase B of
the study. Among those participants eligible from Phase A, participants with a LSHS total score
above 20 (n=51, 21% ) were classified into the STP+ group while those with LSHS total scores
below 20 (n=191, 78% were classified into the STP- group. The LSHS total score of 20 was
selected based on previous research demonstrating this score as approximating the median split
in college student samples (Aleman et al., 2001; Waters et al., 2003).
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Survey Measures (Phase A)
Participants in Phase A of the study completed several self-report measures including
those that were utilized to determine their eligibility for Phase B. This included demographic
information (e.g., sex, ethnicity, gender, age, and years of education), family history of psychosis
diagnosis, language abilities, contraindications for MRI, and questions related to hearing or
visual difficulties, Perceptual abnormalities were assessed using several different self-report
measures. The Chapman Perceptual Abnormality Scale (Chapman et al., 1978) consists of 35
items that assess experiences such as bodily discontinuities and unusual sensory experiences. It
has been validated in a large population of undergraduate students for the assessment of
psychotic experiences (Chapman et al., 1994). The Peters Delusion Inventory (PDI) is a 21-item
scale measure (Peters & Garety, 1996) of delusional beliefs that includes subscales of distress,
preoccupation and conviction.. It has been validated in an undergraduate sample (FonsecaPedrero et al., 2012). The Schizotypal Personality Questionnaire (SPQ) is a 75 item self-report
questionnaire modeled on DSM-IV TR criteria for Schizotypal Personality Disorder (SPD) that
contains subscales for all nine schizotypal traits (Callaway et al., 2014). The measure has been
used extensively in assessing the screening for SPD in both clinical (Chan et al., 2019; Raine,
1991) and healthy individuals (Unterrassner, Wyss, Wotruba, Haker, et al., 2017). The LaunaySlade Hallucinations Scale (LSHS-R) is a 12-item measure frequently used to detect
predisposition to hallucinations in normal individuals (Launay & Slade, 1981). It assesses three
factors include vivid mental events, hallucinations with a religious theme, and auditory and
visual hallucinations experiences (Aleman et al., 2001; Waters et al., 2003).
Participants (Phase B)
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All participants that met inclusion criteria based on Phase A survey data were invited to
participate in Phase B of the study. Twenty-three individuals completed in-person screening
during Phase B, 12 individuals in the STP- group and 11 individuals in the STP+ group. Ten
participants (66%) from the STP- group screened-in, and six of the 11 (54%) STP+ participants
met inclusion criteria. Two of the eight (25%) STP+ participants that screened-in were lost to
follow-up when scheduling the fMRI portion of the study; all of the eligible STP- participants
continued to the second part of the study (Figure 1). Within the STP- group, one individual
(16%) did not complete the fMRI due to a software error. MRS data for the control region were
not collected in two of the nine (22%) participants from the STP- group due to time limitations
and poor fit quality (Figure 1). In total, 15 participants completed Phase B procedures, 13 of
whom (86%) completed all study procedures and provided both task and MRS data for analysis.
Clinical and Neuropsychological Assessments (Phase B)
During the first visit of Phase B, participants were screened through administration of the
Structured Clinical Interview for the Diagnosis of DSM-IV-R disorders (SCID-IV) (First et al.,
2002) to exclude any individuals that meet criteria for a current psychiatric disorder. Six of the
23 participants (26%) enrolled in Phase B (three participants in each group) were excluded due
to currently meeting criteria for the following psychological disorders: AttentionDeficit/Hyperactivity Disorder (n=1), Bipolar Disorder (n=1), Generalized Anxiety Disorder (n=
2), and Major Depressive Disorder (n=2). The remaining individuals (n= 15) were enrolled in the
final phase of the study (Phase B).
To estimate participants’ overall cognitive abilities, participants were administered the
two-subtest form (Vocabulary and Matrix Reasoning subtests) of the Weschler Abbreviated
Scale of Intelligence, Second Edition (WASI-II). The two-test version of the WASI-II provides a
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brief, reliable measure of verbal and perceptual reasoning abilities in order to estimate overall
cognitive abilities (Weschler, 2013). The WASI-II has strong psychometric properties (Dumont
& Willis, 2008) and has been used in both clinical and research settings (Holdnack, Schoenberg,
Lange, & Iverson, 2013; McCrimmon & Smith, 2013). Participants also completed additional
neuropsychological measures including Letter Number Sequencing (LNS) and Digit Symbol
Substitution Test (DSST). LNS is a measure of numeric working memory and demonstrates
superior psychometric properties (Murtagh et al., 2010). It has been specifically investigated in
patients with psychotic illness (Hurford et al., 2011) and correlates strongly with the severity of
positive symptoms (Addington, Liu, et al., 2017; Haut et al., 2000). DSST is a timed measure of
oral and visual processing speed that has been validated in a large normative sample and has
strong psychometric properties (Lezak, Howieson, & Loring, 2004). Both patients with psychosis
(Cornelis et al., 2014) and those with attenuated psychotic symptoms (Paolo Fusar-Poli et al.,
2012) show reduced processing speed performance on the DSST.
fMRI Task and Behavioral Data
All stimuli were presented and responses were recorded through MATLAB Psychtoolbox
3.0 (Hernández Lorca, 2018; Kleiner et al., 2007). A white fixation cross was presented on a
black background throughout each run. The visual stimuli consisted of a 4 x 7 square gray and
black checkerboard pattern. Gray squares were presented at 25% brightness to maximize visual
stimulation. The target auditory stimuli consisted of a 1-kHz tone with a 100-ms ramped
envelope presented with a broadband white noise (130dB PSL). Scanner noise was estimated by
sound-level meter to be at 130dB SPL. Participants were provided with in-ear headphones with
foam earplugs for protection from scanner noise. The attenuation afforded by the headphones
was deemed to be 40dB SPL and therefore target stimuli were adjusted to be presented at 90 dB
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PSL to account for the attenuation. During the task, target tones were presented at 0% (no tone),
25%, 50% and 75% likelihood of detection as determined by the QUEST thresholding paradigm.
Participants who screened-in Phase B Part 2 practiced the condition hallucination task
outside the scanner on a 2017 Apple MacBook Pro laptop with a pair of AKG (Vienna, Austria)
K240 Professional Studio headphones prior to completing the task in the scanner. The task was
run in Matlab Version 2018b through the PsychToolbox 3.0. Task instructions were provided
verbally and participants were tested on their understanding of task instruction during the
practice run. The practice session used the same stimuli, task components, and scanner noise as
the fMRI component. During the practice component, participants responded whether the
auditory stimuli was present as well as their confidence in their response and were required to
achieve over 85% accuracy to continue in the study.
During the fMRI portion of the study, participants completed stimulus thresholding prior
to test runs using the QUEST maximum-likelihood-based procedure (Watson & Pelli, 1983).
Threshold testing determined the stimulus intensity threshold for 75% likelihood of detection of
target stimulus embedded in noise for each participant. Individual psychometric curves were
fitted given participants responses, and stimulus intensity of 25% and 50% detection were
derived based on these psychometric curves. During the main test trials of the experiment, target
tones were presented at levels estimated to correspond to these (75%, 50%, and 25%) likelihoods
of detection. Total trial length during the thresholding procedures was 2500ms. Training trials
establish a relationship between a conditioned stimulus (a clearly-presented 4x7-square
checkerboard pattern, gray on black, presented at 25% brightness), and the unconditioned
stimulus (a 1-kHz tone with 100-ms ramped envelope with broadband white noise presented at
130dB SPBL). Training trials consists of the presentation of a fixation (500-1000ms form trial
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start) followed by presentation of the visual stimulus concurrent with the auditory stimulus for
one second.
Test trials consisted of 12 blocks of 30 trials over 3 blocks per functional run. Unlike
training trials, test trials included target-absent trials (0% threshold) in which the unconditioned
stimulus was not presented. Trial-type relative likelihoods were determined by block number and
trial type presentation was pseudorandomized within block. During the QUEST procedure,
participants reported report whether the tone was present or not present. During training and test
trials, participants reported whether the tone was present and how confident they were in their
answer on a scale from 0 (not confident) to 5 (very confident) over a 2000-ms response period
(Figure 2). Positive responses in the absence of the unconditioned stimulus were considered a
hallucinated percept. When responses were not recorded in time, the stimulus intensity
corresponding to that trial was repeated during the next trial.
MRS Data Collection
All MRI procedures were conducted on a Siemens Prisma 3 Tesla scanner (Berlin,
Germany) with a 64-channel head coil at the University of Connecticut Brain Imaging Research
Center (Storrs, CT). ECG and respiration recordings were conducted using an MRI-compatible
equipment. Participants were provided with in-ear noise-cancelling headphones that ran through
a Silent Scan audio system (Avotec, Stuart, FL) and were provided a 1x2 response box (Current
Designs, Inc., Philadelphia, PA) in their right hand for the task. The task was presented through
the Psychtoolbox application in MATLAB Version R2018a (MathWorks, 2018) running on a PC
and projected onto a 24" BOLDscreen LCD display viewed through a double mirror fitted to the
head coil (Cambridge Research Systems, Kent, UK). Prior to running participants, in-scanner
noise was measured and used to calibrate the decibel output of task audio stimuli.
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Participants completed Localizer, Field Map A/P and Field Map P/A scan sequences
prior to fMRI and MRS scans. Three-dimensional high-resolution anatomical scans were
acquired using a magnetized prepared rapid acquisition gradient echo (MPRAGE) pulse
sequence (Echo time [TE] = 2.98ms, Repetition time [TR] = 2300ms, Flip angle [FA] = 9°,
number of excitations [NEX] = 2) that produced 176 T1-weighted images with a field of view
(FOV) of 26cm and voxel sizes of 1.0 x 1.0 x 1.0mm. Participants were instructed to keep their
head still and watched a movie of their choice during these initial scans. During the task, a
multiband (factor=3) pulse sequence was run (Echo time [TE] = 30.20ms, Repetition time [TR]
= 1070ms, Flip angle [FA] = 57°, number of excitations [NEX] = 2) that produced 60 slices with
a field of view (FOV) of 210mm and voxel sizes of 2.5 x 2.5 x 2.5mm. The thresholding
procedure was five minutes long while training and test trials lasted approximately 40 minutes
(four nine-minute runs).
For the MRS portion of the task, voxel templates were created through the Voxel
Positioning System (Hancock, 2019) pipeline in ParaView (Kitware, Clifton Park, NY), an opensource, multi-platform data visualization application. The dimensions for the MRS volumes of
interest (VOI) were as follows: (1) anterior cingulate cortex (ACC): size 24 x 24 x 21 mm, and
(2) paracentral lobule (PCL): size 20 x 20 x 20mm. The median sagittal plane was selected as a
reference slice for voxel positioning. All of the VOIs were positioned in such a manner as to
avoid the ventricles and skull and minimize the percent white matter and CSF in the VOI.
Manual adjustments were applied for each participant to ensure that the Full Width Half Max
(FWHM) of the spectral peak was below 25 Hz. A Point Resolved Spectroscopy Sequence
(PRESS) sequence (Yahya, Mädler, & Fallone, 2008) was used for glutamate detection (Mullins,
2008) with the following parameters: TR = 2000 ms; TE = 40 ms; 128 signal averages;
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acquisition bandwidth = 2000 Hz. A symmetric-suppression (Mullins et al., 2014) MescherGarwood Point Resolved Spectroscopy Sequence (MEGA-PRESS) (Baeshen et al., 2019;
Dhamala et al., 2019; Mullins et al., 2014) was used for GABA detection with the following
parameters: TR = 2000 ms; TE = 80 ms; 64 signal averages; acquisition bandwidth = 2000 Hz.
During odd-numbered acquisitions, a frequency-selective, Gaussian inversion pulse was applied
to GABA-3CH2 resonance at 1.9 ppm, affecting the weakly J-coupled triplet peak of GABA4

CH2 at 3.01 ppm (EDIT-ON). During even-numbered acquisitions, the same pulse was applied

at 1.5 ppm, symmetrically to the 1.7 ppm coupled macromolecule spins (EDIT-OFF). The
GABA-edited spectrum was obtained from the difference between the EDIT-ON and EDIT-OFF
spectra. For quantification, a shorter measurement (16 averages) of the unsuppressed water
signal from the same volume was obtained. Variable power optimized relaxation delays
(VAPOR) (Tkacl et al., 1999) were applied for water suppression. Shimming was performed
automatically before each acquisition. Three consecutive MEGA-PRESS scans were acquired for
each participant for each region.
Survey and Behavioral Data Analysis
Survey data were collected and exported from Qualtrics through the University of
Connecticut’s Psychological Experiment Pool. All survey data was analyzed in R Studio
(RStudio Team, 2015). Chi-square and unpaired two-sample t-tests were run to examine group
differences in demographic variables and self-reported levels of psychotic-like symptoms, and
auditory stimuli detection threshold. Behavioral data from the fMRI task was analyzed using
custom Matlab scripts provided by Powers and colleagues (2017). An unpaired two-sample t-test
examined between-group differences in detection threshold (db SNR), in the probability of
participants responding “yes” at each detection likelihood (no stimuli present, 25%, 50%, and
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75%). An analysis of variance (ANOVA) was run to determine whether there was a significant
between-group difference in participants’ confidence when responding ‘yes’ or ‘no’ at each
detection likelihood during test trials.
fMRI Data Analysis
Preprocessing and functional analysis was conducted using AFNI (Cox, 1996) and FSL
(FMRIB Software Library). Functional runs from each subject were corrected for slice
acquisition time, realigned to the middle volume of the series, spatially smoothed with a
Gaussian kernel (6 mm FWHM) and the time series was high-pass filtered using Gaussianweighted least-squares (max= 1/128 Hz). Functional data were linearly aligned to Montreal
Neurological Institute (MNI) space. All four task runs were combined into a single run, the first
6 TRs were removed from both imaging data and stimulus timing files. Single subject data were
analyzed using a fixed effects model with task modeled as a canonical hemodynamic response.
For the purpose of analysis, trials were split by response type (“yes” or “no”) and stimulus
intensity (likelihood detection). Contrasts included each response type and detection likelihood
(“0Yes,” “0No,” “25Yes,” “25No,” “50Yes,” “50No”, “75Yes”, and “75No”), and difference in
responding yes versus no to no-tone (“0Yes” – “0No”). For whole brain analysis, statistical maps
used a threshold of p < .01 and one-sided (NN=3) cluster significance of p < .05. The lowest
FDR q-value was 0.9. A region-of-interest (ROI) analysis was conducted for bilateral anterior
cingulate cortex (ACC) and paracentral lobule (PCL) (four regions total). An ROI mask was
created by resampling the statistical dataset to ensure same resolution and boundaries across
subjects and group. Beta weights were extracted for each region and each contrast.
MRS Data Analysis
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MRS data were analyzed using the FID-A (Simpson, Devenyi, Jezzard, Hennessy, &
Near, 2017) toolkit in MATLAB, custom python scripts, FSL (Oxford University, Oxford, UK),
and Tarquin (Wilson, Reynolds, Kauppinen, Arvanitis, & Peet, 2011) to fit the spectra. Custom
python scripts were used to parse the MRS DICOM files, create a VOI mask for each region, and
merge each of the runs (three runs each for PRESS and MEGA-PRESS sequences). Using the
FID-A toolkit, all spectra were phase aligned with reference to water, bad averages were
removed, corrected for frequency drift and phase drift, zero filled from 1024 to 4096, apodized
with a 4 Hz Gaussian filter, and frequency aligned. Initially, spectra were frequency aligned to
N-acetylaspartate (NAA) at 2.02 ppm, however due to the instability of NAA as a reference,
spectra were separately aligned to creatine (Cr) at 3.02 ppm. Normalizing to creatine reduces
intersubject variance attributable to differences in global signal strength and has been shown to
yield reliable GABA concentration estimates (Bogner et al., 2009). Peak integration was used to
quantify total concentrations of each metabolite. The final spectra were visually examined for
artifact and quality of the fit. For each subject, FSL was used to segment tissue volume in order
to derive CSF and white matter volumes which were applied to each VOI and used as control
variables in all statistical analyses.
The ratio of total Glu/total creatine and GABA/total creatine was used for hypothesis
testing. Statistical testing was also conducted using NAA as the denominator in the ratio. For
each statistical test, were entered as control variables. All statistical analysis of group differences
in VOI glutamate and GABA concentrations was conducted in R Studio.

27

Results
Characteristics of Study Subjects
There was no significant between-group difference in age (t (13) = 0.26, p= 0.80), gender
(c2 (1, N=16)= 0.00, p = 1.00), ethnicity, (c2 (1, N=16)= 3.89, p= 0.14, sexual orientation (c2 (1,
N=16)= 0.07, p= 0.79), or number of years of education (t (14)= 0.24, p= 0.82) (Table 1). There
was also no between-group difference in full-scale IQ (FSIQ) (t (13) = 1.40, p= 0.19). These
demographic variables also did not differ significantly between group when only including those
participants that completed all procedures.
Participants completed several self-report measures that assessed their propensity to
experience perceptual abnormalities and delusional beliefs. There was a significant betweengroup difference in total scores on the Launay-Slade Hallucination Scale, (t (14) = -5.42, p <
0.001), which has previously been shown specificity for experiencing auditory hallucinations
(Aleman et al., 2001; Levitan et al., 1996; Waters et al., 2003). There were no between-group
differences on other measures of psychotic-like experiences including perceptual aberrations
(Chapman Total Sore, t (14) = -0.28, p= 0.78), schizotypal traits (SPQ Total Score, t (14) = 1.37, p= 0.19), and delusional beliefs (PDI Total Score, t (14) = -1.59, p= 0.14) (Table 2). There
were also no significant between-group differences on subscales of the SPQ that have previously
been associated with perceptual abnormalities and schizotypal traits such as the
cognitive/perpetual subscale (t (14) = -0.95, p= 0.36), and perceptual abnormalities subscale (t
(14) = -1.78, p= 0.10). Across several different measures of schizotypal traits and susceptibility
to experience perceptual aberrations, the only significant group difference emerged in total
LSHS-R scores.
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In addition to IQ testing, participants that screened into Phase B of the study completed
tests of working memory and processing speed that have been previously demonstrated to differ
between healthy individual and those with psychosis (Cornelis et al., 2014; Murtagh et al., 2010)
as well as those at-risk for psychosis (Addington, Liu, et al., 2017; Paolo Fusar-Poli et al., 2012).
There was also no between-group difference in processing speed as measured by differences in
the average T-score on the Digit Symbol Substitution Test (DSST), (t (14) = 1.35, p= 0.20).
There was also significant between-group difference in working memory abilities as measured
by group differences in average T-score on the Letter Number Sequencing test (LNS), (t (14) =
1.51, p= 0.15).
Task Performance
There was no significant difference in the detection threshold between groups ((t (12) =
1.41, p= 0.18), indicating that differences in task performance were not likely driven by
individual or group differences in the decibel level of the target audio stimuli (Figure 3A).
Participants in the STP+ group were significantly more likely to response “yes” during the notone condition (t (12)= -2.30 , p < .05), however there was no significant differences in the
probability of endorsing a response at the 25% ((t (12) = -1.03, p= 0.32 ), 50% ( (t (12) = -0.04,
p= 0.92), or 75% ((t (12) = -0.06, p= 0.94 ) detection threshold (Figure 3B). Across all
participants, the probability of responding “yes” when there was no tone positively correlated
with self-reported hallucination severity as measured by LSHS-R total scores (R^2= 0.31, p <
.001) (Figure 3C). Overall these results are consistent with previous findings that voice-hearers
without a psychosis diagnosis are more likely to endorse conditioned hallucinations (A R Powers
et al., 2017), and this effect is not accounted for by group differences in auditory detection
thresholding. It is also consistent with previous findings of a strong positive linear relation
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between hallucination severity, as measured by LSHS-R total score, and the probability of
endorsing conditioned hallucinations.
In addition to responding whether or not the tone was detected, participants rated their
level of confidence in their answer during each test trial. Participants rated their confidence
similarly across most conditions. There was no group-by-condition difference in confidence
ratings at the 25% (F (3, 22) = 0.68, p = 0.58), 50% (F (3, 22) = 0.11, p = 0.96), or 75% (F (3,
22) = 3.36, p = 0.07) detection threshold (Figure 3C). However, there was a significant betweengroup difference in confidence ratings in the no-tone (0% detection) condition (F (3, 22) = 3.93,
p =.05), which was driven by a higher confidence in “yes” responses to the no-tone condition in
the STP+ group compared to the STP- group (t (14) = -3.36, p < .01)). This provides further
support for the higher likelihood of endorsing false percepts in the STP+ group being driven by a
strong belief in the association of the conditioned stimuli, rather than less confidence in their
predictions. Yet there was no significant correlation between hallucination severity and the
confidence with which conditioned hallucination were reported (R2= 0.08, p = 0.32). It is likely
that the high variability in confidence ratings in the STP+ group, and low samples size,
decreased the ability to detect and association between confidence ratings and hallucination
severity.
fMRI Results
Whole-brain fMRI analysis revealed few clusters that survived statistical correction.
Cluster-based correction revealed small regions of activation across several contrasts (k < 20).
When responding “yes” to no-tone trials (endorsing conditioned hallucinations), the STP+ group
demonstrated higher activation than the STP- group in several regions previously associated with
the neurobiology of hallucinations (Figure 4) including the cerebellum (k= 6, Z= 3.12, peak at
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20, 31, -45), right middle frontal gyrus (k= 4, Z= 3.19, peak at 25, -52, 3), superior temporal
gyrus (k= 3, Z= 3.13, peak at -43, 6, -15), thalamus (k= 3, Z= 3.12, peak at 20, 31, -45), right
insula (k= 3, Z= 3.12, peak at 20, 31, -45), and right middle cingulate cortex (k= 3, Z= 3.12, peak
at 20, 31, -45). However, there were also clusters in regions that have not been associated with
auditory verbal hallucinations including the brain stem (k= 5, Z= 3.56, peak at 8, 26, -30) and
right cerebellum white matter (k= 3, Z= 3.29, peak at 28, 46, -47). Although these results provide
some evidence that conditioned hallucinations activate the same regions consistent with previous
studies (Zmigrod et al., 2016) on the neurobiology of hallucinations in psychotic disorders, and
that activation patterns appear to differ between groups, these results should be interpreted
cautiously given the sample size, number and size of clusters that survived statistical correction,
and relatively large q value (0.5).
When subtracting “no” responses from “yes” responses during no-tone trials, the STP+
group demonstrated higher levels of activation in several regions hypothesized to be involved in
the neurobiology associated with the overweighting of top down priors including the left inferior
frontal gyrus (k= 18, Z= 3.21, peak at -53, -35, -5), left middle temporal gyrus (k= 15, Z= 3.28,
peak at -55, 26, -2) and right caudate (k= 6, Z= 3.18, peak at 13, -22, -11). The majority of the
clusters that reached statistical significance were also notably small in size (Figure 4B). While
providing some consistent evidence of overlap in the neurobiology of conditioned hallucinators
with hallucinations in psychotic disorders, these results should be interpreted conservatively
given the above-noted limitations of the sample size, cluster-based correction, and whole-brain
exploratory fMRI analysis approach.
Given this study’s a prior hypothesis on the role of ACC glutamate and GABA
dysfunction in the neurobiology of conditioned hallucinations, a region-of-interest (ROI) fMRI
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analysis was conducted for the bilateral ACC and control region (PCL). During conditioned
hallucinations, hallucinators exhibited higher levels of activation in several voxels with the right
ACC (B= 0.57, q= 0.05, p = 0.001) but not the left ACC (Figure 5A). There were also significant
between-group activation differences within the right PCL (B= 0.47, q= 0.05, p = 0.001),
contrary to stated hypotheses (Figure 5B). Similar unilateral patterns of activation differences
emerged in the right ACC (B= 0.45, q= 0.05, p = 0.003) (Figure 5C) and right PCL (B= 0.18, q=
0.05, p = 0.003) (Figure 5D) when subtracting “no” responses from “yes” responses to no-tone
trials. The magnitude of these activation differences was notably smaller compared to the
conditioned hallucinations contrast. There were no between-group differences in the left ACC or
left PCL for either contrast. ROI analysis of the ACC during correct rejections (“no” responses to
no-tone trials) demonstrated lower levels of activation in the STP+ group compared to the STPgroup (not shown), consistent with previous findings (Powers et al., 2017). Given increases in
activation of frontal regions during conditioned hallucinations, consistent with the hypothesis of
overweighting top-down priors, this finding suggests that hallucinators exert less cognitive
control during correct rejections, perhaps due to difficulties with stimulus detection (Wang,
Ulbert, Schomer, Marinkovic, & Halgren, 2005).
MRS Results
A multiple linear regression model was used to examine between group differences in the
ratio of Glu/Cr and GABA/Cr in the ACC compared to the control region, and to examine
between-group differences in cortical excitability (Glu/GABA ratio). For all linear models,
individual differences in the percent of cerebral spinal fluid and percent of white matter were
entered as control variables. While there was no significant group x region interaction in the ratio
of glutamate to creatine, F (2,25) = 1.83, p= 0.18, there was a significant between-group
difference in glutamate concentration in the anterior cingulate cortex, F (1,13) = 4.57, p= 0.05,
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but no such difference in the control region, F (1,11) = 0.77, p= 0.40, (Figure 6A). The finding of
higher levels of ACC Glu/Cr ratio is consistent with predictions and previous MRS studies of
individuals with psychosis (Marsman et al., 2013). The inability to detect a group x region
interaction may have been driven by low variability in PCL Glu/Cr concentrations in the minus
group coupled with high variability in Glu/Cr concentrations in the plus group.
Consistent with hypothesized predictions, there was a statistically significant group x
region interaction in GABA/Cr concentrations, F (2,25) = 15.86, p< 0.0001. Yet, contrary to
predictions, this difference was driven by a larger GABA/Cr ratio in the plus group compared to
the minus group in the PCL, F (1,11) =4.40, p= 0.05, (Figure 6B). There was no between-group
difference in GABA/Cr concentrations in the ACC, F (1,13) = 2.17, p= 0.16.
As glutamate and GABA respectively represent the major excitatory and inhibitory
neurotransmitters in the central nervous system, the ratio of glutamate to GABA is a commonly
utilized measure of cortical excitability (Ford, Nibbs, & Crewther, 2017). To investigate
between-group differences in cortical excitability, the concentration of total glutamate extracted
from the PRESS sequence was divided by total GABA concentrations extracted from the
MEGA-PRESS sequence for each group and each region. Overall there was a significant group x
region interaction in cortical excitability levels, F (2,25) = 5.76, p< 0.01 (Figure 6C). Yet there
was no between-group difference in excitability levels in the ACC, F (1,13) = 1.69, p= 0.22, or
PCL, F (1,11) = 1.40, p= 0.26. This finding provides preliminary support, consistent with
previous findings in psychosis (Overbeek et al., 2019), for the role of reduced cortical
excitability in frontal regions implicated in the neurobiology of psychosis.
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Discussion
The present study aimed to investigate the neurobiology of conditioned hallucinations in
a healthy undergraduate sample that differed in their propensity to endorse perceptual
abnormalities. Overlap in the neural underpinnings of PA in those at risk for psychosis with
hallucinations in psychotic illness may provide important insight into the spectrum of psychotic
experiences and the pathogenesis that contributes to increased risk for conversion. Consistent
with previous research (Powers et al., 2017), hallucinators were more likely to endorse
conditioned hallucinations, and were more confident in their responses. Their responses were
positively correlated with a measure of hallucinatory experiences, and were not due to betweengroup differences in detection thresholding. These results provide further support for the
predictive coding account of hallucinations and the role of expectation, prior learning, and
perceptual knowledge in the etiology of perceptual abnormalities. It demonstrates that
hallucinations can be reliably conditioned not only in those with a psychotic illness or
personality disorder but also along the continuum of healthy individuals who differed in their
propensity for experiencing perceptual aberrations.
Although there was a significant between-group difference in LSHS-R total scores, the
two groups did not differ on several measures of schizotypal traits as measured by the SPQ, nor
did they differ in mean total scores on the Peters et al. Delusions Inventory or the Chapman
Perceptual Aberrations Scale. This may be explained in part by the fully dimensional aspect of
the LSHS-R, which assumes that hallucinations exist on a continuum within the normal
population (Aleman et al., 2001), compared to the quasi-dimensional approach of the Chapman,
which implies that the experience of perceptual abnormalities outside of psychosis represents an
at-risk state (Peters et al., 1995) or a slight variant of psychopathology. While the factor
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structure of the SPQ is fully dimensional in nature, the LSHS-R may be better suited to capture
the specific construct of auditory perceptual abnormalities, whereas there is significant overlap in
the constructs measured across various factors of the SPQ. Although the distribution of scores on
these measures in the prescreening sample was consistent with previously-reported normative
data, the small sample size and large standard deviations of total scores for those included in
scanning procedures suggest the benefit of examining these issues further in a larger sample.
These findings suggest that the present sample may more closely reflect PA in a healthy youngadult population and may be less representative of an at-risk undergraduate sample. This may be
especially helpful for understanding the experience of those who report daily auditory percepts
without the associated distress associated with psychotic illness (Pinheiro et al., 2018; Powers et
al., 2017).
Contrary to hypothesized predictions, there were no between-group differences in FSIQ,
in processing speed, as measured by performance on the Digit-Symbol Substitution Task, or in
working memory abilities, as measured by performance on the Letter-Number Sequencing task.
These findings are consistent with the previously-noted observation of the current sample
perhaps more closely approximating a healthy normative population rather than an at-risk
sample. Yet even in help-seeking CHR individuals, there are inconsistent findings on when
cognitive deficits emerge, their association with conversion likelihood, and the role of baseline
measures in predicting long-term functional outcomes (Bora et al., 2014; Emre Bora & Murray,
2014; Brewer et al., 2006). The most consistent predictive models of conversion risk (Addington,
Liu, et al., 2017) include several factors not examined explicitly in the present study including
baseline social functioning, bizarre thought content, and disordered communication. Several
other studies have also reported no between-group differences in processing speed for both CHR
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(Paolo Fusar-Poli et al., 2012) and psychosis samples (Cornelis et al., 2014). The present study
also did not measure deficits in social cognition, which some (Piskulic et al., 2016; Shakeel et
al., 2019) have noted are more consistent and persistently impaired in CHR individuals over the
entire course of the prodromal period.
fMRI results, which should be interpreted cautiously, were also consistent with previous
findings on the neurobiology of conditioned hallucinations (Powers et al., 2017). Hallucinators
demonstrated decreased activation in the ACC during correct rejections and increased activation
during conditioned hallucinations. Decreased ACC engagement during correct rejections
suggests that even when not experiencing aberrant percepts, hallucinators struggled with accurate
reality monitoring (Wang et al., 2005), perhaps driven the overweighting of top-down prior
perceptual learning. ACC activation has also been associated with perceptual learning related to
conflict monitoring (Yeung & Nieuwenhuis, 2009), which is negatively correlated with error
likelihood. Lower ACC activation patterns are associated with high levels of conflict and higher
cognitive demand in decision-making tasks. This provides additional support for the ACC’s
involvement in the weighting of prediction error during perceptual learning. The ACC is also
critical for cognitive control (Barber & Carter, 2005; Lesh, Niendam, Minzenberg, & Carter,
2011) and the inhibition of prepotent responses, suggesting that lower activation in hallucinators
may indicate less inhibitory control. Notably, group differences in activation were not observed
at other detection threshold levels. Collectively, these findings tentatively provide preliminary
support for the overweighting of top-down priors in conditioned hallucinations. While wholebrain analysis demonstrated activation in regions previously reported in symptom-capture fMRI
studies of AVH (Zmigrod et al., 2016) and conditioned hallucinations (Powers et al., 2017), the
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small sample size limited statistical correction, resulting small cluster sizes and small effect
sizes. A larger sample is required to fully interpret these initial results.
There was a higher ratio of glutamate to creatine in the STP+ group compared to the
STP- group in the ACC, consistent with hypothesized predictions. These differences were not
observed in a control region, providing preliminary support for altered glutamatergic functioning
in the neurobiology of conditioned hallucinations. This finding is consistent with previous metaanalyses of MRS studies (Marsman et al., 2013; Merritt, Egerton, Kempton, Taylor, & McGuire,
2016; Poels et al., 2014). The current results are not confounded by methodological factors that
have likely contributed to mixed findings across previous MRS studies, such as the impact of
medications, (none of the participants reported current psychotropic medication use), or
differences in the percent of white matter and CSF across participants. The PRESS sequencing
technique used in the present study has strong reliability (Baeshen et al., 2019; Yahya et al.,
2008) and utilized a well-established preprocessing pipeline (Simpson et al., 2017). Altered
glutamatergic signaling in prefrontal regions including the ACC has been tied to hallucinations
and psychotic symptoms more broadly across CHR, first-episode, and chronic samples. This is
the first study to demonstrate NMDA-R hypofunction in conditioned hallucinations, suggesting
strong overlap in the neurobiology of perceptual abnormalities and providing support for a
dimensional approach in linking neurobiology to clinical phenomenology.
While there was a significant group by region interaction in ratio of GABA to total
creatine, this was driven by between-group differences in the control region with no group
differences in the ACC. Similarly, a significant group by region difference in cortical excitability
was not associated with between-group differences in the ACC. This may have been driven by
the higher variability of GABA/Cr concentrations within both groups, combined with a lower
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sample due to several participants not being able to complete full MRS scanning procedures.
Meta-analyses of GABA levels in frontal regions have reported mixed results, with one study
finding no differences between psychosis patients (Egerton et al., 2017) and healthy controls and
a more recent, larger study reporting reduced GABA levels in the ACC of patients with
psychosis (Kumar et al., 2020). Null findings in GABA concentration differences have also been
reported in those at ultra-high risk for psychosis (Modinos et al., 2018). While cortical
excitability has been associated with schizotypal traits (Ford et al., 2017) and cognitive abilities
in first-episode patients (Overbeek et al., 2019), the current sample did not differ on any SPQ
factors or total scores, nor did they differ in cognitive abilities. It is likely that the role of altered
GABAergic functioning in psychotic experiences may be most relevant for understanding
systems-level dysfunction and the interaction of frontal regions with other regions putative to
pathogenesis of psychosis, including subcortical and temporal cortical regions(de Jonge et al.,
2017; McCutcheon et al., 2020). A longitudinal study (Modinos et al., 2018) following CHR
individuals over the course of three years report baseline differences in the correlation of
prefrontal GABA levels with regional cerebral blood flow in the hippocampus. Importantly, this
association predicted conversion to psychosis. Future studies with multi-site samples may benefit
from measuring GABA concentrations both within and across networks associated with NMDA
hypofunction.
The current study has several important limitations. Although both behavioral and
neuroimaging results are consistent with results from Powers and colleagues (2017), the small
sample size and large within-group variability suggest a highly cautious interpretation. It is likely
that the current sample reflects the healthier end of the psychosis spectrum and therefore may not
be generalizable to help-seeking at-risk clinical samples. Although the two groups differed in
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their LSHS-R scores, this is unsurprising given that the measure was used to categorize
participants as being high or low in their experience of perceptual abnormalities. It will be
important for future studies of non-help-seeking young adult samples to reproduce the reliability
of the LSHS-R in measuring hallucinations through administration of similar measures with
strong psychometric properties. The PCL was chosen as a control region during MRS procedures
as it is not implicated in the neurobiology of conditioned hallucinations, nor is it consistently
activated in fMRI studies of auditory hallucinations. However, some studies report increased
PCL activation in patients with auditory verbal hallucinations, and the region may be involved in
critical for predictive coding. In addition to behavioral and neuroimaging results, computational
modeling using a hierarchical gaussian filter approach is required to confirm whether confidence
in reporting conditioned hallucinators is associated with the overweighting of top-down prior
beliefs, consistent with predictive coding theory of hallucinations. Although some studies
(Mathalon et al., 2019) suggest a low precision of priors of in the etiology of auditory verbal
hallucinations, this may be specifically relate to the auditory system’s strong bias for speech and
differential disruption of priors at different hierarchical levels from lower sensory cortices to
higher-level order associative cortices (Sterzer et al., 2018). MRS measures both inactive and
active metabolite concentrations, and the majority of physiologically active glutamate is derived
from glutamine (Rowland et al., 2013). Future studies should also examine between-group
differences in glutamine to determine whether Glu/Cr differences may be biased by measurement
of extracellular inactive glutamate.
The current study aimed to build upon previous investigations of the predictive coding
account of hallucinations by examining conditioned hallucinations in healthy, college-aged
individuals who differ in their propensity toward endorsing perceptual aberrations and linking
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the phenomenology of these experiences with the well-established role of prefrontal NMDA
hypofunction in the neurobiology of hallucinations. STP+ individuals were more likely to
endorse conditioned hallucinations and were more confident in their responses, which was
associated with differences in ACC activation and Glu/Cr concentrations, but not GABA/Cr
concentrations nor differences in cortical excitability. Consistent with previous findings of
conditioned hallucinations (Powers et al., 2017) and predictive coding accounts of psychosis
(Horga et al., 2014; Ranson et al., 2019; Sterzer et al., 2018; Teufel et al., 2015), these results
require replication in a larger sample and application of computational techniques to determine
whether these effects are driven by the overweighting of top-down prior beliefs. This is the first
study to replicate the conditioned hallucination effect within the “healthy end” of the psychosis
continuum, and the first study limited to college-aged individuals, a population that is important
for broad-based screening efforts in the early detection and prevention of psychotic illnesses.
While narrow in scope and limited in generalizability, the current study extends previous efforts
(Corlett et al., 2009; Kapur, 2003) to conceptualize the phenomenology of hallucinations and its
underlying neurobiology within a cognitive, computational framework. Continued efforts in this
direction will be critical for not only further characterizing these symptoms, but also for
developing new treatment modalities and biological targets that can improve the lives of those
with psychosis.
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Appendices
All Survey Participants (N= 552)

Incomplete (n=173)

Eligible (n=242)

Ineligible (n=137)

STP- (n=191)

Screened for Phase 2
(n=13)

Screened In
(n=10)

Missing
Task Data
(n= 2)

Screened
Out (n=3)

STP+ (n=51)

Screened for Phase 2
(n= 10)

Screened In
(n=8)

Lost to
Follow-up
(n=2)

Missing
Control
Voxel (n= 2)
STPComplete
Data
(n= 6)

Screened Out
(n=3)

STP+
Complete
Data
(n= 6)

Figure 1. PRISMA Diagram of Participant Recruitment.
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Demographic
N
Age (years)
Sex (% Female)
Ethnicity
Sexual Orientation
Years of Education
FSIQ, Mean (SD)

STP + Group
6
20.14 (0.60)
66.66%
66.6% White
33.3% Black
83.3% Heterosexual
13.5 (0.9)
100 (10)

STP – Group
10
20.82 (2.45)
70.00%
90% White
10% Asian
90% Heterosexual
13.1 (1.3)
108 (11)

p value
(Chi-Square or T-test)
-0.80
1.00
0.14
0.79
0.82
0.19

Table 1. Phase B Participant Demographics. N= number of participants, FSIQ= Full-Scale Intelligence Quotient. P value represents
results of either Chi-Square or independent samples t-test.
Survey Measure
STP + Group (N=6) STP – Group (N=10)
p value
Total LSHS-R Score
29.00 (6.87)
9.10 (7.23)
< 0.001
Total PDI Score
54.83 (24.20)
37.75 (16.18)
0.14
Total SPQ Score
28.17 (15.83)
17.10 (14.26)
0.19
SPQ Perceptual Aberrations
2.83 (2.64)
1.10 (1.29)
0.10
SPQ Cognitive Perceptual
10.17 (7.17)
7.00 (6.00)
0.36
Chapman Total Score
7.83 (6.74)
7.00 (4.99)
0.78
DSST T-Score
53.83 (5.95)
58.10 (6.21)
0.20
LNS T-Score
49.33 (3.33)
56.40 (10.99)
0.15
Table 2. Phase B Self-Report and Cognitive Testing Results.
LSHS-R= Launay-Slade Hallucination Scale Revised; PDI= Peters Delusion Inventory;
SPQ= Schizotypal Personality Questionnaire; Chapman = Chapman Perceptual Aberration Scale;
DSST= Digit Symbol Substitution Task; LNS= Letter Number Sequencing Task
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Figure 2: Participant Pool Survey Results. Violin Plot comparison of all eligible participants total scores on the Cognitive-Perceptual
factor (CP) of the Schizotypal Personality Questionnaire (SPQ) and the Chapman Perceptual Aberration Scale. Red line indicates the
mean SPQ- CP total score in patients with psychosis while the blue line represents SPQ-CP mean in healthy individuals (Raine, 1991).
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R^2 = 0.31, p < .001

n.s.

Figure 3. Task Behavioral Data. There was no significant between-group difference in the detection threshold (dBSNR) levels (3A).
The two groups differed in the probability of responding yes when no tone was presented, but there were no such differences in the
probability of responding yes at the 25%, 50%, or 75% of the detection threshold (3B). The probability of responding yes to no tone
correlated significantly with the LSHS-R total score (3C). The two groups differed in the level of confidence in “yes” versus “no”
responses during the no tone condition, but this difference was not apparent at any other detection threshold level (3D). n.s.= not
significant; * = p < 0.05; **= p < 0.01; ***= p < 0.001.
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4A

4B

Figure 4: Whole-Brain fMRI Results by Condition. Whole-brain analysis was conducted to determine activation during conditioned
hallucinations. Cluster-based correction was utilized with a height threshold of p<.001 and cluster threshold of p<.05. Few clusters
survived correction and all were small (k < 20) in size. Results shown for when participants responded “yes” to no-tone trials
(conditioned hallucinations, 4A) and for differences between responding “yes” versus “no” to no-tone trials (4B). Tables indicates size
of cluster (k), peak coordinates (x, y, z), and magnitude of the effect (Z).
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5A

5B

5C

5D

Figure 5: Region of Interest (ROI) fMRI Results by Condition. ROI analysis was conducted to determine activation in the main region
of interest of the study, the anterior cingulate (ACC), as well as in the control region, the paracentral lobule (PCL) during the
conditioned hallucinations task. In the right ACC (x= -8, y=-32, z=6) there were several regions that demonstrated higher levels of
activation during “yes” responses to no-tone trials (5A). There was also some activation in the right PCL (x= -7, y=-32, z=53) during
this condition (5B). There was also increased activation when comparing “yes” responses to “no” responses in both the right ACC
(5C) and right PCL (5D) but the magnitude of these differences was smaller.
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Figure 6. Magnetic Resonance Spectroscopy Results. Concentrations of total glutamate (ppm) as a ratio to total creatine
concentrations (ppm) were higher in the anterior cingulate cortex (ACC) voxel for the STP Plus (plus) group compared to the STP
Minus (minus) group but there was no between-group difference in the paracentral lobule (PCL) control voxel (6A). There was a
significant group x region interaction in the concentrations of total GABA (ppm) as a percent of total creatine (ppm) concentration
driven by a larger GABA/Cr ration in the plus group than the minus group in the control region (6B). There was a significant group by
region interaction in cortical excitability as measured by the ratio of glutamate to GABA in the two regions (6C). n.s.= not significant;
* = p < 0.05; **= p < 0.01; ***= p < 0.001.
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